Gift Aims to Save Children’s Sight

Ophthalmologist Adam Jacobson, M.D., examines a young patient.
Ophthalmologist Adam Jacobson, M.D., examines a young patient.

Congenital eye disorders are the leading cause of childhood blindness worldwide, but properly diagnosing them is only part of the battle. Saving a child’s sight requires families to coordinate care between highly specialized physicians, which can be overwhelming. While prompt treatment can prevent blindness in most children, far too many kids still lose their sight because they lack access to the complex care they need.

Longtime W.K. Kellogg Eye Center donors Timothy and Laurie Wadhams wanted to help kids at risk of blindness. “I experienced challenges with my eyesight at an early age, and with successful treatment, was able to overcome them,” says Mr. Wadhams. “Laurie and I want to help ensure that treatments exist for all of the diseases that threaten vision.”

The Wadhams recently made a $5 million gift to the Kellogg Eye Center that is poised to change the landscape of children’s eye care by establishing a multidisciplinary programmatic center housed in the pediatric ophthalmology clinic. The goal of the Wadhams Family Center for Children’s Vision is to save and restore sight for children through leading-edge, multidisciplinary care from experts tackling the eye disorders that children are born with from every angle.

Lev Prasov, M.D., Ph.D., assistant professor of ophthalmology and visual sciences and of human genetics, will lead the center. His commitment to exploring the genetics of pediatric eye diseases is improving visual outcomes. “Not only has the Wadhams’ generosity supported cutting-edge research like mine, but their latest gift will help kids with congenital eye disorders get the care needed to save their sight.”

“The W.K Kellogg Eye Center is one of the nation’s few academic institutions that provides children with world-class care across all subspecialties, which means we can treat and advance research for even the most rare and complex diseases,” says Shahzad I. Mian, M.D., F. Bruce Fralick Professor of Ophthalmology and chair of the Department of Ophthalmology and Visual Sciences.

The Wadhams’ previous endowment gift created the Wadhams Family Foundation Children’s Vision Fund as part of the Paul R. Lichter, M.D., M.S. Vision Research Discovery Fund. Together, the fund and center will propel children’s vision care and research to greater heights. Thrilled by their latest gift, Dr. Lichter, past department chair of ophthalmology and visual sciences, founding director of the Kellogg Eye Center, and currently professor emeritus (active) said, “The Wadhams’ visionary investments have already contributed to scientific discovery. Their latest gift will make a life-changing difference for children facing vision loss.”

It is a sentiment with which Paul Lee, M.D., J.D., executive director, U-M Medical Group, senior associate dean, Clinical Affairs, and professor of ophthalmology and visual sciences, agrees, saying, “This investment by the Wadhams toward our shared goal of eliminating childhood vision loss will accelerate remarkable collaborations in research and care. Our fantastic faculty and teams at the Kellogg Eye Center work side-by-side with colleagues from across the University of Michigan campus and around the world.”

The Wadhams Family Center for Children’s Vision is the pinnacle of their ongoing support of children’s vision health, bringing their total giving to the Kellogg Eye Center to more than $6.5 million. When combined with their generosity to other areas across Michigan Medicine and the University of Michigan, their gifts total nearly $17 million. Former Masco Chief Executive Officer Timothy Wadhams and his wife, Laurie, reside in Ann Arbor. Masco is the one of the world’s largest manufacturers of home improvement and building products.

To support our efforts, click on the Wadhams Family Children’s Vision Fund and make your gift today!
 


More Articles About:

Philanthropy W.K. Kellogg Eye Center Eye Care & Vision Genetic Disorders Ophthalmology

Philanthropy News

Discover how donors at Michigan Medicine drive advances in patient care, research, and education. See how philanthropy brings Michigan answers to patients and families.

In This Story

portrait of Lev Prasov

Lev Prasov, MD, PhD

Associate Professor

Featured News & Stories

David Diebold smiles as he rings the bell at the end of the HURT100.
Philanthropy News

Going the extra 100 miles

U-M Medical School student runs the HURT100 ultramarathon to raise funds for the Michigan Alzheimer's Disease Center and the Alzheimer's Association.
Research image of rat blood vessels before and after norrin treatment
Health Lab

Treatment with norrin helped maintain healthy blood vessels, preserved vision in diabetic rats

Study reveals norrin treatment prevents vision loss from diabetic retinopathy in early and late stages, paving the way for new therapies.
Entrance to Adult Emergency Services with an ambulance parked out front.
Philanthropy News

Small comforts make a world of difference

Thanks to donor support, upgrades like warm blankets, comfortable seating, and snacks are now available in Adult Emergency Services at Michigan Medicine.
Portrait of Dr. Rosen smiling and seated at a table.
Philanthropy News

Continuing the legacy of a doctor’s doctor

As he faced a serious cancer diagnosis, David Rosen, M.D, made a gift to the U-M Division of Adolescent Medicine that will continue his legacy for decades to come.
Members of the nephrology care team and Coulson family at the recent awards ceremony.
Philanthropy News

Family’s gift honors wife and mother, supports nephrology nurses

The Coulson family is honoring Barbara Coulson's memory by recognizing exceptional dialysis nurses and investing in professional development that will strengthen patient care.
Gene editing, conceptual illustration. DNA (deoxyribonucleic acid) double helix under a magnifying glass
Health Lab

Gene editing is coming for common diseases. Are we ready?

Gene therapies may offer one-time treatment for disease, but experts say safety, reversibility, cost and long-term monitoring must guide use.